Live feed
Filing
SC 13G/A
SC 13G/A0000921895-20-003303·BIOTECHNOLOGY VALUE FUND L P
Schedule 13G ownership disclosure
Tokai Pharmaceuticals Inc
Security class unavailable · CUSIP: 67011N204
Event date: 2020-12-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-20-003303
- Form type
- SC 13G/A
- Filer
- BIOTECHNOLOGY VALUE FUND L P
- CIK
- CIK 918923
- Filed
- Dec 30, 2020
- Reporting period
- Dec 28, 2020
- Description
- Schedule 13G beneficial ownership